Replies to post #78008 on NanoViricides Inc. (NNVC)

[ZincFinger]

You see only what fits your agenda. NNVC met their projection for starting the preliminary toxicology study. (Last time I checked, "July, give or take a month or two" covers September.)

While it's true that "We won't know for sure whether Flucide works in humans until Phase II trials are completed" that's conveniently ignoring that the current evidence is very strong although not definitive.

1) 100% of Flucide treated animals alive after 21 days when all untreated animals dead in 5 and "standard of care" treated animals dead in 7.

2) since the mechanism of the drug is independent of the host (because it acts directly on the virus) that evidence is far more directly related to effects in humans than the usual case where drugs interact with host's metabolisms, giving a huge potential for results varying between hosts.

Again, you appear to see only what suits your agenda. That tends to give very poor results in the stock market.

[Echo20]

JG36

I see your points.

Now go to the statements by Dr Seymour on NNVC CIDE that state the medicine goes after the virus and not the body and so it does not matter what body it is in.

NNVC CIDES are non-toxic and that is a big plus.

Other than that the official testing is for FLUCIDE and the CIDES as well as any other new medicine and that is the way all pharmaceuticals go with.

Best of luck to FLUCIDE and NNVC in 2014.

Echo20